Cancer scientists in Britain are launching what they call the world's first Darwinian drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients. Read full article
Comments
Disclaimer & comment rulesCommenting for this story is now closed.
If you have a Facebook account, become a fan and comment on our Facebook Page!